A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

Nearly 30,000 people in England living with chronic obstructive pulmonary disease could see their lives transformed after the ...

Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...

Have you tried cough syrup but are still experiencing constant coughing throughout the day? For instant relief from dry to wet coughs, experts recommend a few home remedies.  | Health ...

Some people continue coughing after they recover from a common respiratory infection. Doctors explain why a cough can last ...

Here’s what to know about how VapoRub can provide relief, who should use caution and who should avoid it altogether.

"A common flu or cough does not last more than three to five days. If it carries on for more than that, it could be something serious," Dr Harish Chafle, senior consultant and chest physician, who ...

You might not realise it, but some of your everyday routines are keeping that winter cough stubbornly hanging around.

From December 4 to 6, 2025, the 5th International Cough Conference (ICC) was successfully held in Guangzhou, China. This event focused on the theme of “refractory chronic cough,” bringing together ...

(Sharecast News) - Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD). Following ...